High-Price Drugs: time to roar back?

ESMO and INAHTA to lead a new Decide working group on High-Price Drugs

 

Decide’s board members the European Society for Medical Oncology (ESMO) and the International Network of Agencies for HTA (INAHTA) decided recently to design and lead a new joint workstream to offer country decision makers operational solutions when faced with soaring prices of health technologies.

 

This working group will, once its conceptual framework is ready and set up call for expressions of interest of experts to participate in its work programme. No doubt that the proximity of the Fair Pricing Forum team now hosted on the Decide platform will help!

 

Consistent with its mission statement, this working group will commit to share insight, co-create knowledge and produce an operational supporting tool to help secure value for money of choices through data, analytics, negotiation and empowerment.

 

Stay tuned to know more about this work stream!

Comments:

For adding comments please sign up or log in